Search Results 2151-2160 of 21703 for platelets

1. Sports Medicine - Doctors - Mayo Clinic

   Areas of focus: Regenerative medicine therapy, Microfragmented fat injection, Ultrasound-guided musculoskeletal injection, Platelet ric...h plasma injection ...

2. Study to Assess the Effectiveness and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone to Treat Patients with Previously Treated Non-Hodgkins Lymphoma - Mayo Clinic

   Absolute neutrophil count (ANC) > 1,000/mm^3 (µL) & platelet count > 50,000/mm^3 (µL);; Total bilirubin ≤ 1.5 times the upper limit of normal (ULN);; Alanine ...

3. A Study to Evaluate the Safety and Effectiveness of Intratumoral and Intravenous Injection of Vesicular Stomatitis Virus Expressing Human Interferon Beta, and Tyrosinase Related Protein 1 (VSV-IFNb-TYRP1) in Patients with Metastatic Ocular Melanoma and Previously Treated Patients with Unresectable Stage III/IV Cutaneous Melanoma - Mayo Clinic

   Platelet count ≥ 100,000/mm^3;; Hemoglobin ≥ 9.0 g/dL (without need for hematopoietic growth factor or transfusion support);; Alanine aminotransferase (ALT) ...

4. Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma - Mayo Clinic

   Platelet count ≥ 100,000/mm^3;; Hemoglobin > 9.0 g/dL or ≥ 5.6 mmol/L without transfusion or (EPO) erythropoietin dependency (within 7 days of assessment); ...

5. Pembrolizumab and Ibrutinib in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery - Mayo Clinic

   Platelet count ≥ 75,000/mm^3*;; Hemoglobin ≥ 9.0 g/dL;; Total bilirubin ≤ 1.5 X upper limit of normal (ULN); if total bilirubin > 1.5 X ULN then direct ...

6. Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery - Mayo Clinic

   Platelets ≥ 1 X 10^6 cells/mm^3 (100,000) based upon complete blood count (CBC); Hemoglobin ≥ 10.0 g/dl based upon CBC (Note: The use of transfusion or ...

7. Everolimus and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma - Mayo Clinic

   Platelet (PLT) ≥ 75,000/uL; Serum total bilirubin within normal range (or ≤ 1.5 x upper limit of normal [ULN] if liver metastases are present; or total ...

8. Phase 2 Study Of ALXN2030 In Patients With Antibody-Mediated Rejection After Kidney Transplantation - Mayo Clinic

   * Platelets < 100 × 109/L * Leucocytes < 3 × 109/L * Neutrophils < 1.5 × 109/L * Multiorgan transplant recipient (except for previous multiple kidney ...

9. Funding - Division of Emergency Medicine Research

   Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial (U01NS062835-06), National Institute of Neurological Disorders and Stroke, 05 ...

10. Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform - Mayo Clinic

    Platelet count ≥100,000/mm^3;; Total bilirubin ≤ 1.5 x ULN;; Alanine aminotransferase (ALT) and aspartate transaminase (AST) ≤ 3 x ULN (≤ 5 x ULN for ...